×
About 7,518 results

ALLMedicine™ Gastritis Center

Research & Reviews  2,454 results

Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative p...
https://doi.org/10.1136/gutjnl-2022-327827
Gut Rugge M, Bricca L et. al.

Jul 1st, 2022 - Autoimmune gastritis (AIG) is an immunomediated disease targeting parietal cells, eventually resulting in oxyntic-restricted atrophy. This long-term follow-up study aimed at elucidating the natural history, histological phenotype(s), and associate...

Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apopto...
https://doi.org/10.1371/journal.ppat.1010628
PLoS Pathogens; Palrasu M, Zaika E et. al.

Jun 30th, 2022 - Helicobacter pylori (H. pylori) is a common gastric pathogen that infects approximately half of the world's population. Infection with H. pylori can lead to diverse pathological conditions, including chronic gastritis, peptic ulcer disease, and ca...

The relationship between helicobacter pylori infection and nodular antral gastritis in ...
https://doi.org/10.1016/j.jnma.2022.05.011
Journal of the National Medical Association; Yorulmaz A, Emiroğlu HH et. al.

Jun 29th, 2022 - Helicobacter pylori (H. pylori) is a spiral-shaped gram-negative bacterium that colonizes the gastric mucosa. It is a common infectious agent in children. In this study, we aim to evaluate the demographic data, and the clinical and histopathologic...

Plasma Exosomal hsa_circ_0015286 as a Potential Diagnostic and Prognostic Biomarker for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218071
Pathology Oncology Research : POR; Zheng P, Gao H et. al.

Jun 28th, 2022 - Circular RNA (circRNA) is stable and abundant in exosomes as a potential biomarker for the diagnosis and prognosis of tumor. In this study, cancer specific exosomal circRNAs were identified through circRNA microarray, and 58 circRNAs were signific...

Diagnoses after newly recorded abdominal pain in primary care: observational cohort study.
https://doi.org/10.3399/BJGP.2021.0709
The British Journal of General Practice : the Journal of ... Price SJ, Gibson N et. al.

Jun 28th, 2022 - Non-acute abdominal pain in primary care is diagnostically challenging. To quantify the 1-year cumulative incidence of 35 non-malignant diagnoses and nine cancers in adults after newly recorded abdominal pain in primary care. Observational cohort ...

see more →

Guidelines  5 results

ACR Appropriateness Criteria® Epigastric Pain.
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.

Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740554
Gastroenterology Shah SC, Piazuelo MB et. al.

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

Appropriate use of special stains for identifying Helicobacter pylori: Recommendations ...
https://doi.org/10.1097/PAS.0000000000000097
The American Journal of Surgical Pathology; Batts KP, Ketover S et. al.

Oct 22nd, 2013 - Helicobacter pylori is a major cause of gastroduodenal injury, gastric cancer, and lymphoma, and, thus, there is great interest in its detection and eradication. Several detection methods are available, including histochemical and immunohistochemi...

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367502
Endoscopy Dinis-Ribeiro M, Areia M et. al.

Dec 27th, 2011 - Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with th...

see more →

Drugs  131 results see all →

Clinicaltrials.gov  245 results

Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer
https://clinicaltrials.gov/ct2/show/NCT05344339

Jun 28th, 2022 - Since the first gastrectomy by Theodore Billroth in 1881, this procedure remained a curative treatment for gastric cancer. Reconstruction method after gastrectomy may affect complication rates, post-operative nutritional status, and quality of lif...

Dupilumab in Eosinophilic Gastritis
https://clinicaltrials.gov/ct2/show/NCT03678545

Jun 21st, 2022 - This is a phase 2, multi-center, randomized, double-blind, placebo-controlled trial testing the efficacy of dupilumab vs. placebo in EG. Qualifying subjects will be randomized 1:1 to either study drug (dupilumab) or placebo, and will receive 600 m...

Study of Gastric Motility in EG
https://clinicaltrials.gov/ct2/show/NCT05229432

Jun 21st, 2022 - Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in the natural history of EG but is underdiagnosed due,...

Narrow Band Imaging for Gastric Neoplasia
https://clinicaltrials.gov/ct2/show/NCT02197351

Jun 15th, 2022 - 1 BACKGROUND Precursor Lesions Gastric cancer is the fourth most common cancer and second leading cause of malignant death in the world. It often presents only with vague symptoms of dyspepsia and consequently is frequently diagnosed at advanced s...

Phase III FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
https://clinicaltrials.gov/ct2/show/NCT01926197

Jun 14th, 2022 - A Pancreatic Cancer Radiotherapy Study Group (PanCRS) Trial Primary Objective: To determine progression free survival for mFFX +/- SBRT. Secondary Objectives: To determine metastasis free survival following mFFX chemotherapy alone or with SBRT. To...

see more →

News  163 results

A guide to GERD, H pylori infection, and Barrett esophagus
https://www.mdedge.com/familymedicine/article/255367/gastroenterology/guide-gerd-h-pylori-infection-and-barrett-esophagus
MDedge Family Medicine; Megan Everson, MD, Alice M. Boshoven, MD et. al.

Jun 13th, 2022 - Three conditions seen in primary care—gastroesophageal reflux disease (GERD), Helicobacter pylori (H pylori) infection, and Barrett esophagus (BE)—evolve in a gastric acid environment and are treated in part through gastric acid suppression. While.

New German Guideline for H. pylori Infection Coming Soon
https://www.medscape.com/viewarticle/975301

Jun 9th, 2022 - The updated German guideline for Helicobacter pylori therapy is expected to be published in June or July. Unlike the previous version, it will state for the first time that experts recommend an infection be treated as soon as it is detected, regar...

Commentary: Gastric Cancer Chemotherapy in Select Populations, June 2022
https://www.mdedge.com/hematology-oncology/article/255104/gastrointestinal-cancer/commentary-gastric-cancer-chemotherapy
Nataliya Uboha, MD, PhD

Jun 1st, 2022 - Dr. Nataliya Uboha, MD Chemotherapy plays a critical role in the management of patients with advanced gastroesophageal adenocarcinoma, and a fluoropyrimidine and platinum doublet (either oxaliplatin or cisplatin) is the standard regimen used.

Eosinophilic Diseases Often Overlap, Raising Costs
https://www.medscape.com/viewarticle/974781

May 27th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U.S. Optum Clinformatics claims database. EADs have gained increased attenti...

Eosinophilic diseases often overlap, raising costs
https://www.mdedge.com/internalmedicine/article/255002/gastroenterology/eosinophilic-diseases-often-overlap-raising-costs
Jim Kling

May 26th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U. S.

see more →

Patient Education  9 results see all →